Browse > Article
http://dx.doi.org/10.11620/IJOB.2015.40.2.063

Apoptotic Activity of Curcumin and EF-24 in HTB-41 Human Salivary Gland Epidermoid Carcinoma Cells  

Kim, Ji-Won (Oral Biology Research Institute, Chosun University School of Dentistry)
Lee, Seul Ah (Oral Biology Research Institute, Chosun University School of Dentistry)
Go, Dae-San (Oral Biology Research Institute, Chosun University School of Dentistry)
Park, Byung-Sun (Oral Biology Research Institute, Chosun University School of Dentistry)
Kim, Su-Gwan (Oral Biology Research Institute, Chosun University School of Dentistry)
Yu, Sun-Kyoung (Oral Biology Research Institute, Chosun University School of Dentistry)
Oh, Ji-Su (Oral Biology Research Institute, Chosun University School of Dentistry)
Kim, Chun Sung (Oral Biology Research Institute, Chosun University School of Dentistry)
Kim, Jeongsun (Department of Dental Hygiene, Gwangju Health University)
Park, Jong-Tae (Department of Oral Anatomy, Dankook University School of Dentistry)
Kim, Do Kyung (Oral Biology Research Institute, Chosun University School of Dentistry)
Publication Information
International Journal of Oral Biology / v.40, no.2, 2015 , pp. 63-69 More about this Journal
Abstract
Curcumin (diferuloylmethane), a constituent of turmeric powder derived from the rhizome of Curcuma longa, has been shown to inhibit the growth of various types of cancer cells by regulating cell proliferation and apoptosis. However, a need exists to design more effective analogs because of curcumin's poor intestinal absorption. EF-24 (diphenyl difluoroketone), the monoketone analog of curcumin, has shown good efficacy in anticancer screens. However, the effects of curcumin and EF-24 on salivary gland epidermoid carcinoma cells are not clearly established. The main goal of this study was to investigate the effects of curcumin and EF-24 on cell growth and induction of apoptosis in human salivary gland epidermoid carcinoma cells. Our studies showed that curcumin and EF-24 inhibited the growth of HTB-41 cells in a dose- and time-dependent manner, and the potency of EF-24 was > 34-fold that of curcumin. Treatment with curcumin or EF-24 resulted in nuclear condensation and fragmentation in HTB-41 cells, whereas the control HTB-41 cell nuclei retained their normal regular and oval shape. Curcumin and EF-24 promoted proteolytic cleavages of procaspase-3/-7/-9, resulting in an increase in the amount of cleaved caspase-3/-7/-9 in the HTB-41 cells. Caspase-3 and -7 activities were detected in viable HTB-41 cells treated with curcumin or EF-24. These results suggest that the curcumin and EF-24 inhibit cell proliferation and induce apoptosis in HTB-41 human salivary gland epidermoid carcinoma cells, and that they may have potential properties as an anti-cancer drug therapy.
Keywords
EF-24; curcumin; cell death; apoptosis; salivary gland epidermoid carcinoma cells;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol. 2003;25:213-224.   DOI
2 Sahu RP, Batra1 S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer. 2009;100:1425-1433. doi: 10.1038/sj.bjc.6605039.   DOI
3 Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol. 2007;73:1024-1032. doi: 10.1016/j.bcp.2006.12.010.   DOI
4 Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vene R, Dell''Eva R, Jochum M, Albini A, Pfeffer U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem. 2007;19:137-152. doi:10.1159/000099202.   DOI
5 Hauser PJ, Han Z, Sindhwani P, Hurst RE. Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix. Anticancer Res. 2007;27: 737-740.
6 Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 30-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30:905-918. doi: 10.3892/ijo.30.4.905.   DOI
7 Wahl H, Tan L, Griffith K, Choi M, Liu JR. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol. 2007;105:104-112. doi:10.1016/j.ygyno.2006.10.050.   DOI
8 Ammon HP, Wahl MA. Pharmacol Curcuma longa. Planta Med. 1991;57:1-7. doi: 10.1055/s-2006-960004.   DOI
9 Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8:229-240. doi: 10.1034/j.1601-0825.2002.02870.x.   DOI
10 Ellis GL, Auclair PL, Gnepp DR. Surgical pathology of the salivary glands. In: Primary squamous cell carcinoma (Auclair PL and Ellis GL, eds.). Philadelphia, W. B. Saunders Company, 1991. pp. 369-378.
11 Cheng YL, Lee SC, Lin SZ, Chang WL, Chen YL, Tsai NM, Liu YC, Tzao C, Yu DS, Harn HJ. Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo. Cancer Lett. 2005;222:183-193. doi:10.1016/j.canlet.2004.10.015.   DOI
12 Park DI, Lee JH, Moon SK, Kim CH, Lee YT, Cheong J, Choi BT, Choi YH. Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiforum in human lung carcinama cells. Pharmacol Res. 2005;51:437-443. doi:10.1016/j.phrs.2004.11.003.   DOI
13 Tan ML, Suaiman SF, Najimuddin N, Smian MR, Tengku Muhammad TS. Methanolic extract of Pereskia bleo (Kunth) DC. (Cactaceae) induces apoptosis in breast carcinama, T47-D cell line. J Ethnopharmacol. 2005;96:287-294. doi:10.1016/j.jep.2004.09.025.   DOI
14 Hoshino T, Hara A, Inoue M, Honda J, Imai Y, Oizumi K, Yokoyama MM. Flow cytometric measurement of NK cell cytotoxicity. J Clin Lab Immunol. 1991;36:39-43.
15 Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redoxdependent mechanism. Anticancer Drugs. 2005;16:263-275.   DOI
16 Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol. 2008;75:787-809. doi: 10.1016/j.bcp.2007.08.016.   DOI
17 Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807-818. doi:10.1021/mp700113r.   DOI
18 Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR, Snyder JP, Liotta DC, Shoji M. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem. 2004;12:3871-3883. doi: 10.1016/j.bmc.2004.05.006.   DOI
19 Lee MH, Kim MM, Kook JK, Kim DK, Kim HR, Kim HJ, Kim CS. Ethanol extracts of Angelica decursiva induces apoptosis in human oral cancer cells. Int J Oral Biol. 2010;35:215-220.
20 Shin WC, Kim CS, Kim HJ, Lee MH, Kim HR, Kim DK. Growth inhibition of human head and neck squamous cell carcinomas by Angelica decursiva extracts. Int J Oral Biol. 2010;35:153-158.
21 Kim JY, Kim HS, Kang HS, Choi JS, Yokozawa T, Chung HY. Antioxidant potential of dimethyl lithospermate isolated from Salvia miltiorrhiza (red sage) against peroxynitrite. J Med Food. 2008;11:21-28. doi:10.1089/jmf.2007.040.   DOI
22 Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1308-1312. doi:10.1126/science.281.5381.1309.   DOI
23 Tian Z, Chen S, Zhang Y, Huang M, Shi L, Huang F, Fong C, Yang M, Xiao P. The cytotoxicity of naturally occurring styryl lactones. Phytomedicine. 2006;13:181-186. doi:10.1016/j.phymed.2004.07.010.   DOI
24 Smets LA. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drug. 1994;5:3-9.
25 Paschka AG, Butler R, Young CYF. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 1998;130:1-7. doi: 10.1016/S0304-3835(98)00084-6.   DOI
26 Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776. doi: 10.1038/35037710.   DOI
27 Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 2001;11:526-534. doi: 10.1016/S0962-8924(01)02173-0.   DOI
28 Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 2000;256:42-49. odoi: 10.1006/excr.2000.4838.   DOI
29 Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med. 2001;7:314-319. doi:10.1016/S1471-4914(01)02026-3.   DOI
30 Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20:7597-7609.   DOI
31 Miquel J, Bernd A, Sempere JM, Diaz-Alperi J, Ramirez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr. 2002;34:37-46. doi: 10.1016/S0167-4943(01)00194-7.   DOI
32 Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 1997;89: 175-184. doi: 10.1016/S0092-8674(00)80197-X.   DOI
33 Kim CS, Moon IS, Park JH, Shin WC, Chun HS, Lee SY, Kook JK, Kim HJ, Park JC, Endou H, Kanai Y, Lee BK, Kim DK. Inhibition of L-type amino acid transporter modulates the expression of cell cycle regulatory factors in KB oral cancer cells. Biol Pharm Bull. 2010;33:1117-1121. http://doi.org/10.1248/bpb.33.1117.   DOI
34 Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16.   DOI
35 Datta R, Kojima H, Yoshida K, Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem. 1997;272:20317-20320. doi:10.1074/jbc.272.33.20317.   DOI
36 Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003;4:721-729. doi:10.1016/S1470-2045(03)01277-4.   DOI
37 Christou L, Hatzimichael E, Chaidos A, Tsiara S, Bourantas KL. Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone. Eur J Haematol. 2001;67:51-53. doi: 10.1034/j.1600-0609.2001.067001051.x.   DOI
38 Mukherjee AK, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr Med Chem. 2001;8:1467-1486. doi: 10.2174/0929867013372094.   DOI
39 Pezutto JM. Plant-derived anticancer agents. Biochem Pharmacol. 1997;53:121-133. doi:10.1016/S0006-2952(96)00654-5.   DOI
40 van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett. 1997;114:195-202. doi: 10.1016/S0304-3835(97)04662-4.   DOI